4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-054530
Chief Scientific Officer gave up 1,041 shares (to pay taxes)
- Chief Scientific Officer acquired 2,333 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Monahan Joseph Chief Scientific Officer | 2021-09-01 | Option exercise | +2,333 | 87,675 | D | ||
| Monahan Joseph Chief Scientific Officer | 2021-09-01 | Shares withheld for taxes | −1,041 | $17.22 | $17,926 | 86,634 | D |
| Derivatives | |||||||
| Monahan Joseph Chief Scientific Officer | 2021-09-01 | Option exercise · Restricted Stock Units | −2,333 | 0 | D | ||
Loading xslF345X03/doc4.xml…